Search
for
Sort by
Research 121–150 of 1000+
- Adverse events in patients treated with Jak‐inhibitors for alopecia areata: A systematic review
- Therapeutic expansion of JAK inhibitors in Chinese dermatological practice: beyond atopic dermatitis to novel autoimmune frontiers
- Real‐World Outcomes and Safety of JAK Inhibitors in Paediatric Alopecia Areata: A Retrospective Multicentre Study
- A Discrete Choice Experiment of Clinician Preferences Among Attributes of Approved Janus Kinase Inhibitors for Alopecia Areata
- 73571 The real-world impact of JAK inhibitor treatment on anxiety and depression outcomes and the role of eyebrow and eyelash hair regrowth in alopecia areata: TARGET-DERM
- The Role of JAK Inhibitors in Atopic Dermatitis, Alopecia Areata, and Vitiligo: A Review article
- Use of Jak Inhibitors in the Treatment of Alopecia Areata
- Comparative Efficacy of JAK Inhibitors in Acute vs Nonacute Alopecia Areata: A Retrospective Cohort Study
- Clinical positioning and future prospects of JAK inhibitors in alopecia areata
- JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology
- Irish dermatologists’ experience with JAK inhibitors in alopecia areata
- “<i>Nomen Omen</i>: The Myth of God Janus”
- Treatment of alopecia areata with JAK inhibitors
- Evaluating Current and Emergent JAK Inhibitors for Alopecia Areata: A Narrative Review
- INIBIDORES DA JANUS QUINASE PARA O TRATAMENTO DA ALOPECIA AREATA
- Jak inhibitors in the treatment of alopecia areata - a literature review
- Screening for latent infectious disease in patients with alopecia areata before initiating JAK inhibitors therapy: a single-center real-world retrospective study
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- Alopecia Universalis Treated With Tofacitinib: The Role of JAK/STAT Inhibitors in Hair Regrowth
- Rebound effect associated with JAK inhibitor use in the treatment of alopecia areata
- 075 Clinical investigation of JAK inhibitor Tofacitinib in scarring alopecias
- 43647 Treatment of Refractory Folliculitis Decalvans with the Topical JAK Inhibitor Tofacitinib
- Real-world experience quantifying access to JAK inhibitor care for alopecia areata patients: a patient-centered survey study
- JAK-inhibitors. New players in the field of immune-mediated diseases, beyond rheumatoid arthritis
- JAK INHIBITORS IN THE PATHOGENESIS OF ALOPECIA AREATA
- JAK INHIBITORS IN THE PATHOGENESIS OF ALOPECIA AREATA
- Inhibidores de JAK: usos en dermatología. Parte 1: generalidades, aplicaciones en vitíligo y en alopecia areata
- 77200 Infections and Therapy Lapses Predominate as Flare Triggers on Oral JAK Inhibitors for Alopecia Areata: A Retrospective Cohort Study
- Alopecia areata
- Topical Ruxolitinib for the Treatment of Alopecia Universalis